A novel method for predicting hepatocellular carcinoma response to chemoembolization using an intraprocedural CT hepatic arteriography-based enhancement mapping: a proof-of-concept analysis

[1]  Bin Zhang,et al.  Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep learning based on digital subtraction angiography videos , 2022, Cancer Imaging.

[2]  Yan Guo,et al.  Applying arterial enhancement fraction (AEF) texture features to predict the tumor response in hepatocellular carcinoma (HCC) treated with Transarterial chemoembolization (TACE) , 2021, Cancer Imaging.

[3]  A. K. Jones,et al.  Comparison of radiation dose and image quality between flat panel computed tomography and multidetector computed tomography in a hybrid CT‐angiography suite , 2020, Journal of applied clinical medical physics.

[4]  E. Levy,et al.  Assessment of the response of hepatocellular carcinoma to interventional radiology treatments. , 2019, Future oncology.

[5]  A. Jones,et al.  Comparative Analysis of Intra-arterial Cone-Beam Versus Conventional Computed Tomography During Hepatic Arteriography for Transarterial Chemoembolization Planning , 2018, CardioVascular and Interventional Radiology.

[6]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[7]  M. Abecassis,et al.  AASLD guidelines for the treatment of hepatocellular carcinoma , 2018, Hepatology.

[8]  D. Kirsch,et al.  Assessment of Response to Transcatheter Arterial Chemoembolization with Doxorubicin-eluting Microspheres: Tumor Biology and Hepatocellular Carcinoma Recurrence in a 5-year Transplant Cohort. , 2017, Radiology.

[9]  K. Awai,et al.  Change in Imaging Findings on Angiography-Assisted CT During Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma , 2016, CardioVascular and Interventional Radiology.

[10]  Hiroshi Honda,et al.  Hemodynamic changes under balloon occlusion of hepatic artery: predictor of the short-term therapeutic effect of balloon-occluded transcatheter arterial chemolipiodolization using miriplatin for hepatocellular carcinoma , 2016, SpringerPlus.

[11]  L. Zender,et al.  Parenchymal Blood Volume Assessed by C-Arm–Based Computed Tomography in Immediate Posttreatment Evaluation of Drug-Eluting Bead Transarterial Chemoembolization in Hepatocellular Carcinoma , 2016, Investigative radiology.

[12]  D. Sze,et al.  Watershed Hepatocellular Carcinomas: The Risk of Incomplete Response following Transhepatic Arterial Chemoembolization. , 2015, Journal of vascular and interventional radiology : JVIR.

[13]  Myeong-Jin Kim,et al.  Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma. , 2015, Journal of hepatology.

[14]  B. Choi,et al.  Estimation of Hepatic Extracellular Volume Fraction Using Multiphasic Liver Computed Tomography for Hepatic Fibrosis Grading , 2015, Investigative radiology.

[15]  K. Kichikawa,et al.  Current role of hybrid CT/angiography system compared with C-arm cone beam CT for interventional oncology. , 2014, The British journal of radiology.

[16]  Toby C. Cornish,et al.  Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis. , 2014, Radiology.

[17]  T. Seo,et al.  Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. , 2013, Journal of hepatology.

[18]  Zhengjia Chen,et al.  mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE). , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  J. Geschwind,et al.  Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma? , 2013, Radiology.

[20]  B. Choi,et al.  Detection of Recurrent Hepatocellular Carcinoma in Cirrhotic Liver after Transcatheter Arterial Chemoembolization: Value of Quantitative Color Mapping of the Arterial Enhancement Fraction of the Liver , 2012, Korean journal of radiology.

[21]  M. Abrams,et al.  Value of noncontrast CT immediately after transarterial chemoembolization of hepatocellular carcinoma with drug-eluting beads. , 2012, Journal of vascular and interventional radiology : JVIR.

[22]  Chih-Wei Lee,et al.  Efficacy of transarterial chemoembolization for hepatocellular carcinoma in interlobar watershed zone of liver: comparison of unilateral and bilateral chemoembolization. , 2012, Journal of vascular and interventional radiology : JVIR.

[23]  Y. Shin,et al.  Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models. , 2012, Radiology.

[24]  Tim Meyer,et al.  EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization. , 2011, Journal of hepatology.

[25]  R. Günther,et al.  Volumetric arterial enhancement fraction predicts tumor recurrence after hepatic radiofrequency ablation of liver metastases: initial results. , 2011, AJR. American journal of roentgenology.

[26]  R. Badawi,et al.  Semiautomated segmentation for volumetric analysis of intratumoral ethiodol uptake and subsequent tumor necrosis after chemoembolization. , 2010, AJR. American journal of roentgenology.

[27]  O. Matsui,et al.  The March of Extrahepatic Collaterals: Analysis of Blood Supply to Hepatocellular Carcinoma Located in the Bare Area of the Liver After Chemoembolization , 2010, CardioVascular and Interventional Radiology.

[28]  Nishita Kothary,et al.  Utility of C-arm CT in patients with hepatocellular carcinoma undergoing transhepatic arterial chemoembolization. , 2010, Journal of vascular and interventional radiology : JVIR.

[29]  Riccardo Lencioni,et al.  Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma , 2010, Seminars in liver disease.

[30]  Ernst Klotz,et al.  Quantitative CT color mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma. , 2009, Radiology.

[31]  T. Ochiai,et al.  Communicating arcade between the right and left hepatic arteries: evaluation with CT and angiography during temporary balloon occlusion of the right or left hepatic artery. , 2005, Radiology.

[32]  H. Ueno,et al.  Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. , 2001, AJR. American journal of roentgenology.

[33]  Y. I. Kim,et al.  Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. , 1992, Radiology.

[34]  S. Wallace,et al.  Hepatic arterial redistribution for intraarterial infusion of hepatic neoplasms. , 1980, Radiology.

[35]  M. Dumont,et al.  European Association for the Study of the Liver , 1971 .

[36]  I. Sheen,et al.  Complete response at first transarterial chemoembolization predicts favorable outcome in hepatocellular carcinoma. , 2021, American journal of cancer research.

[37]  Byung Gil Choi,et al.  Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response. , 2013, Journal of vascular and interventional radiology : JVIR.

[38]  M. Wallace,et al.  Hepatocellular Carcinomas within the Milan Criteria: Predictors of Histologic Necrosis after Drug-eluting Beads Transarterial Chemoembolization , 2013, CardioVascular and Interventional Radiology.

[39]  V. Mazzaferro,et al.  EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer , 2012 .

[40]  Riccardo Lencioni,et al.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. , 2012, Journal of hepatology.

[41]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[42]  C. Eurvilaichit,et al.  Hepatic arterial collaterals after transcatheter oily chemoembolization of hepatocellular carcinoma. , 2001, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.